First Time Loading...

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 162.35 USD -2.95%
Updated: Apr 26, 2024

Abbvie Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Abbvie Inc
Gross Profit Peer Comparison

Comparables:
GILD
AMGN
MRNA
VRTX
REGN

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Abbvie Inc
NYSE:ABBV
Gross Profit
$36.1B
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
10%
Gilead Sciences Inc
NASDAQ:GILD
Gross Profit
$21.1B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
10%
Amgen Inc
NASDAQ:AMGN
Gross Profit
$19.8B
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
3%
Moderna Inc
NASDAQ:MRNA
Gross Profit
$2.2B
CAGR 3-Years
39%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Gross Profit
$8.6B
CAGR 3-Years
16%
CAGR 5-Years
27%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Gross Profit
$11.3B
CAGR 3-Years
15%
CAGR 5-Years
12%
CAGR 10-Years
19%

See Also

What is Abbvie Inc's Gross Profit?
Gross Profit
36.1B USD

Based on the financial report for Dec 31, 2023, Abbvie Inc's Gross Profit amounts to 36.1B USD.

What is Abbvie Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
10%

Over the last year, the Gross Profit growth was -13%. The average annual Gross Profit growth rates for Abbvie Inc have been 6% over the past three years , 7% over the past five years , and 10% over the past ten years .